Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer

Clinical trial NCT04517838 · RECRUITING

Trial details

NCT number: NCT04517838
Sponsor: Mayo Clinic
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Adenocarcinoma HER2-Positive Breast Carcinoma Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8

Start date: 2020-07-31
Primary completion: 2028-07-27
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.